KBP Biosciences snags $76 mln Series A
Princeton, New Jersey-based KBP Biosciences, a biotech company focused on developing medicines in areas of unmet medical need, has secured $76 million in Series A financing. Advantech Capital and SDIC Venture Capital led the round with participation from Sangel Capital, Ping An Ventures, Bay City Capital GF XINDE Life Science Investment Fund, Efung Capital, CASH Capital, Cowin Capital Group, Korea Investment Partners and Elite Capital.
5 January 2018•1 min read
